ticlopidine has been researched along with hypericum in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gurbel, PA; Lau, WC; Rubenfire, M; Shields, T; Tantry, US; Welch, TD | 1 |
Barbato, E; Toth, G; Trana, C; Wijns, W | 1 |
2 trial(s) available for ticlopidine and hypericum
Article | Year |
---|---|
The effect of St John's Wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity.
Topics: Aged; Aryl Hydrocarbon Hydroxylases; Blood Platelets; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Double-Blind Method; Female; Humans; Hypericum; Liver; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors | 2011 |
St. John's Wort in patients non-responders to clopidogrel undergoing percutaneous coronary intervention: a single-center randomized open-label trial (St. John's Trial).
Topics: Aged; Analysis of Variance; Belgium; Blood Platelets; Chi-Square Distribution; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hypericum; Male; Middle Aged; Percutaneous Coronary Intervention; Phytotherapy; Plant Extracts; Plants, Medicinal; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Ticlopidine; Time Factors; Treatment Outcome | 2013 |